This is a routine executive-compensation disclosure, not a business update. The filing reports no revenue, earnings, guidance, financing, acquisition, or capital-allocation change; it documents a performance stock-option grant to Deborah Andrews under the company’s equity plan (Grant Notice). Because the event is an award agreement rather than a change in operating expectations, there is no meaningful consensus beat-or-miss comparison.
The award is meaningful only if STAAR’s share price reaches demanding long-term hurdles. Andrews receives options on 29,159 shares at a $24.12 exercise price, divided across three tranches tied to a 60-day volume-weighted average share price of $50, $75, and $100 (Performance Vesting). The shares are not immediately exercisable and do not become earned merely because the stock rises briefly; each hurdle must be reached during the performance period.
| Vesting tranche | Shares | Stock-price hurdle | Exercise price |
|---|---|---|---|
| 1 | 9,122 | $50.00 | $24.12 |
| 2 | 9,679 | $75.00 | $24.12 |
| 3 | 10,358 | $100.00 | $24.12 |
| Total | 29,159 | — | $24.12 |
The structure is designed to retain the executive while tying value to sustained stock performance. One-third of each tranche time-vests after 12 months, with the remaining two-thirds vesting monthly through the 36-month anniversary; a tranche becomes exercisable only when it is both time-vested and performance-vested (Vesting; Vested Option). Any tranche that never clears its hurdle is forfeited, even if its time-vesting schedule is complete.
Change-in-control and termination provisions provide additional protection, but do not change the routine nature of the filing. In a change in control, the transaction price can be used instead of the 60-day VWAP to determine which hurdles are met; a qualifying termination within 12 months afterward can fully time-vest an assumed, continued, or substituted award (Performance Vesting; Termination). Before a change in control, an involuntary termination without cause or resignation for good reason gives already time-vested portions a 90-day window to clear the performance hurdle (Termination).
One administrative inconsistency is worth noting. The filing date is August 6, 2026, while the stated grant date is August 14, 2026, which is eight days later (Grant Notice). That may reflect a drafting or filing-date error; the filing does not explain it. Overall, the disclosure is expected compensation-plan mechanics rather than a new fundamental signal.
Read the original 8-K on SEC EDGAR ↗